HungaroTrial has received Clinical Trial Approval for a new COVID-19 phase II. clinical trial in Romania with a special investigational product blocking the cytokine storm cascade and in this way preventing the development of serious complications. Our team has managed to fast track the clinical trial approval within less than 2 weeks and we are excited to start patient enrolment.
A positive outcome of this development program could provide an effective medication to treat serious COVID-19 cases by saving lives all over the world.
HungaroTrial team is fully committed to advance this project as fast as possible.